Research Trends of Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer: A Bibliometric Analysis
Drug Design, Development and Therapy · 2025-03 · Volume 19 · 1703-1719
DOI: 10.2147/dddt.s510031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-03. Verfasst von Xiaoyan Chang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Protein Kinase Inhibitors, Bibliometrics, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Zitieren
APA
Chang, X., Wang, C., & Zhang, L. (2025). Research Trends of Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer: A Bibliometric Analysis. Drug Design, Development and Therapy, Volume 19, 1703-1719. https://doi.org/10.2147/dddt.s510031
Vancouver
Chang X, Wang C, Zhang L. Research Trends of Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer: A Bibliometric Analysis. Drug Design, Development and Therapy. 2025;Volume 19:1703-1719. doi:10.2147/dddt.s510031
BibTeX
@article{Chang2025,
author = {Chang, Xiaoyan and Wang, Chenghao and Zhang, Linyou},
title = {Research Trends of Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer: A Bibliometric Analysis},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {1703--1719},
doi = {10.2147/dddt.s510031}
}
EUVIMED